Despite its ubiquitous expression and essential function in the body, Hsp90 inhibition has emerged as an attractive strategy for cancer treatment by enabling the inactivation of many of the multiple proteins that conspire in tumourigenesis (Calderwood 2018). Here, HSP90AA1 is linked to cancer.